Search Results

Dasatinib: Pleural effusion in an elderly patient: case report

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 19-19(1)

Publisher: Adis International

Optimizing regional infusion treatment strategies for melanoma of the extremities

Authors: Coleman, Andrew; Augustine, Christina K; Beasley, Georgia; Sanders, Gretchen; Tyler, Douglas

Source: Expert Review of Anticancer Therapy, Volume 9, Number 11, November 2009 , pp. 1599-1609(11)

Publisher: Expert Reviews

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

Authors: Sillaber, C.; Herrmann, H.; Bennett, K.; Rix, U.; Baumgartner, C.; Böhm, A.; Herndlhofer, S.; Tschachler, E.; Superti-Furga, G.; Jäger, U.; Valent, P.

Source: European Journal of Clinical Investigation, Volume 39, Number 12, December 2009 , pp. 1098-1109(12)

Publisher: Blackwell Publishing

Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro

Authors: Amrein, Lilian; Panasci, Lawrence; Gibson, Spencer B.; Johnston, James B.; Soulières, Denis; Aloyz, Raquel

Source: British Journal of Haematology, Volume 147, Number 3, November 2009 , pp. 396-398(3)

Publisher: Blackwell Publishing

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

Authors: Hegedűs, C; Özvegy-Laczka, C; Apáti, Á; Magócsi, M; Német, K; Őrfi, L; Kéri, G; Katona, M; Takáts, Z; Váradi, A; Szakács, G; Sarkadi, B

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 1153-1164(12)

Publisher: Blackwell Publishing

in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)

Authors: Marfe, Gabriella; Stefano, Carla D.

Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 5, Number 1, January 2010 , pp. 58-68(11)

Publisher: Bentham Science Publishers

Molecular Targets in Malignant Pleural Mesothelioma Treatment

Authors: Pasello, Giulia; Favaretto, Adolfo

Source: Current Drug Targets, Volume 10, Number 12, December 2009 , pp. 1235-1244(10)

Publisher: Bentham Science Publishers

Dasatinib: Haemorrhagic colitis and pericardial effusion in a child: case report

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 12-12(1)

Publisher: Adis International

Dasatinib/imatinib: Hepatotoxicity, cancer and fatal multiple-organ failure: case report

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 12-13(2)

Publisher: Adis International

SEVERE HEMORRHAGIC COLITIS CAUSED BY DASATINIB IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

Authors: Shimokaze, Tomoyuki; Mitsui, Tetsuo; Takeda, Hiroaki; Kawakami, Takako; Arai, Takahiko; Ito, Masafumi; Iwaba, Akiko; Izumino, Hiroko; Takahashi, Noriyuki; Kanno, Miyako; Sendo, Dai; Hayasaka, Kiyoshi

Source: Pediatric Hematology and Oncology, Volume 26, Number 6, 2009 , pp. 448-453(6)

Publisher: Informa Healthcare

Dasatinib: Pulmonary arterial hypertension and right ventricular failure: case report

Source: Reactions, Volume 1, Number 1268, 2009-09-05 , pp. 15-15(1)

Publisher: Adis International

Effect of a proton pump inhibitor on the pharmacokinetics of imatinib

Authors: Egorin, Merrill J.; Shah, Dhvani D.; Christner, Susan M.; Yerk, Mara A.; Komazec, Kristin A.; Appleman, Leonard R.; Redner, Robert L.; Miller, Brian M.; Beumer, Jan H.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 3, September 2009 , pp. 370-374(5)

Publisher: Blackwell Publishing

The role of tyrosine kinase inhibitors in tuberous sclerosis

Authors: Koluman, Başak; Yegin, Zeynep Arzu; Yağcı, Münci

Source: British Journal of Haematology, Volume 147, Number 1, October 2009 , pp. 152-153(2)

Publisher: Blackwell Publishing

Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects

Authors: Hartmann, Jorg T.; Haap, Michael; Kopp, Hans-Georg; Lipp, Hans-Peter

Source: Current Drug Metabolism, Volume 10, Number 5, June 2009 , pp. 470-481(12)

Publisher: Bentham Science Publishers

Dasatinib [Sprycel] is to be funded in New Zealand

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 584, 2009-08-08 , pp. 10-10(1)

Publisher: Adis International

Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia

Authors: Tecchio, Cristina; Nichele, Ilaria; Todeschini, Giuseppe; Pizzolo, Giovanni; Ambrosetti, Achille

Source: British Journal of Haematology, Volume 146, Number 2, July 2009 , pp. 222-223(2)

Publisher: Blackwell Publishing

Dasatinib-related bleeding "mild and manageable"

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 5-5(1)

Publisher: Adis International

Dasatinib: First report of hair depigmentation: case report

Source: Reactions, Volume 1, Number 1257, 2009-06-20 , pp. 17-17(1)

Publisher: Adis International

Dasatinib: First report of pulmonary arterial hypertension: case report

Source: Reactions, Volume 1, Number 1253, 2009-05-23 , pp. 13-13(1)

Publisher: Adis International

Pharmacoeconomic benefits of dasatinib in the treatment of imatinib-resistant patients with chronic myelogenous leukemia

Authors: Taylor, Matthew J; Scuffham, Paul A

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 9, Number 2, April 2009 , pp. 117-121(5)

Publisher: Expert Reviews